Forest Labs
Article Abstract:
The price appreciation potential of the shares of Forest Laboratories Inc. for the years 2010-2012 is discussed. The New York, New York-based company manufactures drugs used for treating depression, pain, and cardiovascular and respiratory disorders.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Pharmaceutical preparations, Pharmaceutical industry, Forest Laboratories Inc., FRX, Analyst report
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Affymetrix Inc
Article Abstract:
The price appreciation potential of the shares of Affymetrix Inc. for the years 2011-2013 is discussed. The Santa Clara, California-based company manufactures tools for human genome analysis.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Commercial physical research, Biological products exc. diagnostic, Biotechnology industry, Biotechnology industries, Affymetrix Inc., AFFX
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Evaluation, Stocks, Securities, Stock prices, Company securities
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.